Unknown

Dataset Information

0

Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors.


ABSTRACT: The Food and Drug Administration-approved antifungal agent, itraconazole (ITZ), has been increasingly studied for its novel biological properties. In particular, ITZ inhibits the hedgehog (Hh) signaling pathway and has the potential to serve as an anticancer chemotherapeutic against several Hh-dependent malignancies. We have extended our studies on ITZ analogues as Hh pathway inhibitors through the design, synthesis, and evaluation of novel des-triazole ITZ analogues that incorporate modifications to the triazolone/side chain region of the scaffold. Our overall results suggest that the triazolone/side chain region can be replaced with various functionalities (hydrazine carboxamides and meta-substituted amides) resulting in improved potency when compared to ITZ. Our studies also indicate that the stereochemical orientation of the dioxolane ring is important for both potent Hh pathway inhibition and compound stability. Finally, our studies suggest that the ITZ scaffold can be successfully modified in terms of functionality and stereochemistry to further improve its anti-Hh potency and physicochemical properties.

SUBMITTER: Pace JR 

PROVIDER: S-EPMC7450990 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors.

Pace Jennifer R JR   Teske Kelly A KA   Chau Lianne Q LQ   Dash Radha Charan RC   Zaino Angela M AM   Wechsler-Reya Robert J RJ   Hadden M Kyle MK  

Journal of medicinal chemistry 20190405 8


The Food and Drug Administration-approved antifungal agent, itraconazole (ITZ), has been increasingly studied for its novel biological properties. In particular, ITZ inhibits the hedgehog (Hh) signaling pathway and has the potential to serve as an anticancer chemotherapeutic against several Hh-dependent malignancies. We have extended our studies on ITZ analogues as Hh pathway inhibitors through the design, synthesis, and evaluation of novel des-triazole ITZ analogues that incorporate modificatio  ...[more]

Similar Datasets

| S-EPMC6358021 | biostudies-literature
| S-EPMC6746188 | biostudies-literature
| S-EPMC4025875 | biostudies-other
| S-EPMC6942223 | biostudies-literature
| S-EPMC4039177 | biostudies-literature
| S-EPMC3116172 | biostudies-literature
| S-EPMC8033608 | biostudies-literature
| S-EPMC2530892 | biostudies-literature